MedTrace Logo

Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia

NCT01139307 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2016-02-23

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood or tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in samples from patients with Down syndrome and acute megakaryoblastic leukemia.

Conditions

Interventions

OTHER

cell culture procedure

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • John Crispino, PhD · Robert H. Lurie Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2012-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01139307 on ClinicalTrials.gov